2′f-Arabinonucleic acids (2′F-ANA) - History, properties, and new frontiers

Canadian Journal of Chemistry

Volumn 86, Issue 7, 2008, Pages 641-656

  Watts, Jonathan K ^a   Damha, Masad J ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

2 F ANA; Antisense oligonucleotides; Arabinonucleic acids; Modified oligonucleotides; SiRNA

Indexed keywords

ACIDS; BINDING ENERGY; CHEMICAL PROPERTIES; CHEMICAL STABILITY; NUCLEOTIDES; OLIGONUCLEOTIDES; SHAPE OPTIMIZATION; STRUCTURAL OPTIMIZATION;

(PL) PROPERTIES; ANTISENSE (AS); APTAMERS; BINDING AFFINITIES; COMPLEMENTARY STRANDS; ENZYMATIC SYNTHESES; GENE-SILENCING; HIGHER ORDER STRUCTURES; HYDROLYTIC STABILITY; LOOK-AHEAD; OLIGO NUCLEOTIDES; RNASE H; TRIPLEXES;

SYNTHESIS (CHEMICAL);

EID: 46249131334     PISSN: 00084042     EISSN: None     Source Type: Journal    
DOI: 10.1139/V08-049     Document Type: Article

References (158)

1. J.A. Wright, N.E Taylor, and J.J. Fox. J. Org. Chem. 34, 2632 (1969).
2. J.A. Wright. D.P. Wilson, and J.J. Fox. J. Med. Chem. 13, 269 (1970).
3. See the excellent review hy K.W. Pankiewicz, Carbohydr. Res. 327, 87 (2000). and references therein.
4. L.W. Hertel, G.B. Boder, J.S. Kroin, S.M. Rinzel, G.A. Poore, G.C. Todd, and G.B. Grindey. Cancer Res. 50, 4417 (1990).
5. A. Graul, J. Silvestre. and J. Castaner. Drugs Future. 23, 1176 (1998).
6. V.E. Marquez, C.K.H. Tseng, H. Mitsuya, S. Aoki, J.A. Kelley, H. Ford, J.S. Roth, S. Broder, D.G. Johns, and J.S. Driscoll. J. Med. Chem. 33, 978 (1990).
7. J.D. Stoeckler, C.A. Bell. R.E. Parks, Jr.. C.K. Chu, J.J. Fox, and M. Ikehara. Biochem. Pharmacol. 31, 1723 (1982).
8. K.A. Watanabe, U. Reichman, K. Hirota, C. Lopez, and J.J. Fox. J. Med. Chem. 22, 21 (1979).
9. (a) R.F. Schinazi, J. Peters, M.K. Sokol, and A.J. Nahmias. Antimicrob. Agents Chemother. 24, 95 (1983);
10. (b) M.D Trousdale. A.B. Nesburn, T.L. Su, C. Lopez, K.A. Watanabe, and J.J. Fox. Antimicrob. Agents Chemother. 23, 808 (1983).
11. J.H. Burchenal, T.-C. Chou. L. Lokys, R.S. Smith, K.A. Watanabe, T.-L. Su, and J.J. Fox. Cancer Res. 42, 2598 (1982).
12. J.L. Abbruzzese, S. Schmidt, M.N. Raber, J.K. Levy, A.M. Castellanos, S.S. Legha, and I.H. Krakoff. Invest. New Drugs. 7, 195 (1989).
13. X.-B. Kong, A.C. Scheck, R.W. Price, P.M. Vidal, M.P. Fanucchi, K.A. Watanabe, J.J. Fox, and T.-C. Chou. Antiviral Res. 10, 153 (1988).
14. J.L. Ruth and Y.-C. Cheng. Mol. Pharmacol. 20, 415 (1981).
15. H. Marquardt, J. Westendorf. and H. Marquardt. Carcinogenesis. 3, 593 (1982).
16. H. Marquardt and H. Marquardt. Cancer, 40. 1930 (1977).
17. (a) C. Chu, T. Ma, K. Shanmuganathan, C. Wang, Y. Xiang. S. Pai, G. Yao, J. Sommadossi, and Y. Cheng. Antimicrob. Agents Chemother. 39, 979 (1995);
18. (b) S. Balakrishna Pai. S. Liu, Y. Zhu, C. Chu, and Y. Cheng. Antimicrob. Agents Chemother. 40, 380 (1996);
19. (c) G.-Q. Yao, S.-H. Liu, E. Chou, M. Kukhanova, C.K. Chu, and Y.-C. Cheng. Biochem. Pharmacol. 51, 941 (1996).
20. T. Ma, S.B. Pai. Y.L. Zhu, J.S. Lin, K. Shanmuganathan, J. Du. C. Wang. H. Kim, M.G. Newton, Y.C. Cheng, and C.K. Chu. J. Med. Chem. 39, 2835 (1996).
21. P. Marcellin, H. Mommeja-Marin, S.L. Sacks. G.K.K. Lau, D. Sereni, J.-P. Bronowicki, B. Conway, C. Trepo, M.R. Blum, B.C. Yoo. E. Mondou. J. Sorbel, A. Snow, F. Rousseau, and H.-S. Lee. Hepatology, 40, 140 (2004).
22. C. Lopez, K.A. Watanabe. and J.J. Fox. Antimicrob. Agents Chemother. 17, 803 (1980).
23. F.S. Philips, A. Feinberg, T.-C. Chou, P.M. Vidal, T.-L. Su, K.A. Watanabe, and J.J. Fox. Cancer Res. 43, 3619 (1983).
24. R. McKenzie, M.W. Fried, R. Sallie, H. Conjeevaram, A.M. Di Bisceglie. Y. Park, B. Savarese, D. Kleiner. M. Tsokos, C. Luciano, T. Pruett, J.L. Stotka, S.E. Straus, and J.H. Hoofnagle. N. Engl. J. Med. 333. 1099 (1995).
25. Also see the helpful editorial by M.N. Swartz. N. Engl. J. Med. 333. 1146 (1995)
26. and commentary by A. Bari, L. Josephson, A.M. Prince, W. Lewis, F.W. Perrino, M. Gordon. J. Hoofnagle. R. McKenzie, S. Straus, M.N. Swartz. and J.L. Stotka. N. Engl. J. Med. 334, 1135 (1996).
27. Review of the fialuridine (FIAU) clinical trials. Edited by F. Manning and M. Swartz. National Academy Press, Washington, DC 1995.
28. J.J. Fox, K.A. Watanabe, T.C. Chou, R.F. Schinazi, K.F. Soike, I. Fourel, G. Hantz, and C. Trepo. Antiviral activities of 2′-fluorinated arabinosyl-pyrimidine nucleosides. In Fluorinated carbohydrates: chemical and biochemical aspects; ACS symposium series. Vol. 374. Edited by N.R Taylor. American Chemical Society, Washington, DC. 1988. p. 176.
29. (a) T.C. Chou, X.B. Kong, M.P. Fanucchi, Y.C. Cheng, K. Takahashi, K.A. Watanabe, and J.J. Fox. Antimicrob. Agents Chemother. 31, 1355 (1987);
30. (b) MM. Mansuri, I. Ghazzouli. M.S. Chen, H.G. Howell, P.R. Brodfuehrer, D.A. Benigni, and J.C. Martin. J. Med. Chem. 30, 867 (1987).
31. (a) S.S. Gambhir. Nat. Rev. Cancer 2, 683 (2002);
32. (b) A.R. Buursma, V Rutgers, G.A.P. Hospers, N.H. Mulder, W. Vaalburg, and E.F.J, de Vries. Nucl. Med. Commun. 27, 25 (2006).
33. C. Bettegowda, C.A. Foss, I. Cheong, Y. Wang, L. Diaz, N. Agrawal, J. Fox, J. Dick, L.H. Dang, S. Zhou, K.W. Kinzler, B. Vogelstein, and M.G. Pomper. Proc. Natl. Acad. Sci. U.S.A. 102, 1145 (2005).
34. H. Sun, T.J. Mangner. J.M. Collins, O. Muzik, K. Douglas, and A.F. Shields. J. Nucl. Med. 46, 292 (2005).
35. B. Leyland-Jones, H. Donnelly, S. Groshen, P. Myskowski, A.L. Donner, M. Fanucchi, and J. Fox. J. Infect. Dis. 154, 430 (1986).
36. R. McKenzie, M.W. Fried, R. Sallie. H. Conjeevaram, A.M. Di Bisceglie, Y Park, B. Savarese. D. Kleiner, M. Tsokos, C. Luciano, T. Pruett, J.L. Stotka. S.E. Straus, and J.H. Hoofnagle. N. Engl. J. Med. 333, 1099 (1995).
37. C.-H. Pui, S. Jeha, and P. Kirkpatrick. Nat. Rev. Drug Discov. 4, 369 (2005).
38. P.L. Bonate, L. Arthaud, W.R. Cantrell, K. Stephenson. J.A. Secrist, and S. Weitman. Nat. Rev. Drug Discov. 5, 855 (2006).
39. C.K. Chu, J. Matulicadamic, J.T. Huang, T.C. Chou. J.H. Burchenal, J.J. Fox. and K.A. Watanabe. Chem. Pharm. Bull. (Tokyo) 37, 336 (1989).
40. (a) D.S. Shewach, P.E. Daddona. E. Ashcraft, and B.S. Mitchell. Cancer Res. 45, 1008 (1985);
41. (b) V. Verhoef and A. Fridland. Cancer Res. 45, 3646 (1985).
42. S. Faded, V. Gandhi, M.J. Keating, S. Jeha. W. Plunkett, and H.M. Kantarjian. Cancer, 103, 1985 (2005).
43. J.A. Montgomery, A.T. Shortnacy-Fowler, S.D. Clayton, J.M. Riordan, and J.A. Secrist. J. Med. Chem. 35, 397 (1992).
44. D. Carson, D. Wasson, L. Esparza, C. Carrera, T. Kipps, and H. Cottam. Proc. Natl. Acad. Sci. USA. 89, 2970 (1992).
45. W.B. Parker, S.C. Shaddix, C.-H. Chang, E.L. White. L.M. Rose. R.W. Brockman, A.T. Shortnacy, J.A. Montgomery. J.A. Secrist III, and L.L. Bennett, Jr. Cancer Res. 51, 2386 (1991).
46. O.D. Schaerer and G.L. Verdine. J. Am. Chem. Soc. 117, 10781 (1995).
47. M.-J. Rubira, M.-L. Jimeno, J. Balzarini, M.-J. Camarasa, and M.-J. Perez-Perez. Tetrahedron, 54, 8223 (1998).
48. U. Reichman, K.A. Watanabe, and J.J. Fox. Carbohydr. Res. 42, 233 (1975).
49. C.D. Anderson, L. Goodman, and B.R. Baker. J. Am. Chem. Soc. 80, 5247 (1958).
50. C.H. Tann, P.R. Brodfuehrer, S.P. Brundidge. C. Sapino, and H.G. Howell. J. Org. Chem. 50, 3644 (1985).
51. P.R. Brodfuehrer, C. Sapino. and H.G. Howell. J. Org. Chem. 50, 2597 (1985).
52. C.J. Wilds and M.J. Damha. Nucleic Acids Res. 28, 3625 (2000).
53. J. Yin, D.S. Zarkowsky, D.W. Thomas, M.M. Zhao, and M.A. Huffman. Org. Lett. 6, 1465 (2004).
54. T.S. Chou, L.M. Becke, J.C. O'Toole, M.A. Carr, and B.E. Parker. Tetrahedron Lett. 37. 17 (1996).
55. M.M. Alauddin, P.S. Conti, T. Mathew, J.D. Fissekis, G.K. Surya Prakash, and K.A. Watanabe. J. Fluorine Chem, 106, 87 (2000).
56. W.J. Middleton. J. Org. Chem. 40, 574 (1975).
57. (a) J.A. Wilkinson. Chem. Rev. 92, 505 (1992);
58. (b) R.D. Chambers. Fluorine in organic chemistry. Blackwell Publishing Ltd., Oxford. 2004.
59. M.L. Sznaidman, M.R. Almond, and A. Pesyan. Nucleosides Nucleotides Nucl. Acids, 21. 155 (2002).
60. H.G. Howell, P.R. Brodfuehrer, S.P. Brundidge, D.A. Benigni, and C. Sapino. Jr. J. Org. Chem. 53. 85 (1988).
61. J. Garcia, A. Diaz-Rodriguez, S. Fernandez, Y.S. Sanghvi, M. Ferrero, and V. Gotor. J. Org. Chem. 71, 9765 (2006).
62. K.W. Pankiewicz and K.A. Watanabe. J. Fluorine Chem. 64, 15 (1993).
63. T. Maruyama, S. Takamatsu. S. Kozai, Y. Satoh, and K. Izawa. Chem. Pharm. Bull. (Tokyo) 47, 966 (1999).
64. (a) J.A. Montgomery, A.T. Shortnacy. D.A. Carson, and J.A. Secrist. J. Med. Chem. 29. 2389 (1986);
65. (b) T. Ma, J.-S. Lin. M.G. Newton, Y.-C. Cheng, and C.K. Chu. J. Med. Chem. 40. 2750 (1997).
66. T. Tennila, E. Azhayeva, J. Vepsalainen, R. Laatikainen, A. Azhayev, and I.A. Mikhailopulo. Nucleosides Nucleotides Nucl. Acids, 19, 1861 (2000).
67. M.I. Elzagheid, K. Viazovkina, and M.J. Damha. Synthesis of protected 2′-deoxy-2′-fluoro-β-D-arabinonucleosides. In Current protocols in nucleic acid chemistry. Edited by S. Beaucage. Vol. 1.7. 2002. p. Unit 1.7.
68. M.I. Elzagheid, E. Viazovkina, and M.J. Damha. Nucleosides Nucleotides Nucl. Acids. 22, 1339 (2003).
69. E. Viazovkina, M.M. Mangos, M.I. Elzagheid, and M.J. Damha. Synthesis of 2′-fluoroarabino nucleoside phosphor-amidites and their use in the synthesis of 2′F-ANA. In Current protocols in nucleic acid chemistiy. Edited by S. Beaucage. Vol. 4.15. 2002. p. Unit 4.15.
70. I. Rosenberg, J.F. Soler, Z. Tocik, W.Y. Ren, L.A. Ciszewski, P. Kois. K.W. Pankiewicz. M. Spassova, and K.A. Watanabe. Nucleosides Nucleotides. 12, 381 (1993).
71. P. Kois. Z. Tocik, M. Spassova, W.Y. Ren, I. Rosenberg. J.F. Soler. and K.A. Watanabe. Nucleosides Nucleotides 12, 1093 (1993).
72. H. Ikeda. R. Fernandez, A. Wilk, J.J. Barchi, X.L. Huang, and V.E. Marquez. Nucleic Acids Res. 26, 2237 (1998).
73. I. Berger, V. Tereshko. H. Ikeda. V.E. Marquez. and M. Egli. Nucleic Acids Res. 26, 2473 (1998).
74. (a) K.K. Ogilvie, D.P.C. McGee, S.M. Boisvert, G.H. Hakimelahi, and Z.A. Proba. Can. J. Chem. 61, 1204 (1983);
75. (b) U.O. Cheriyan and K.K. Ogilvie. Nucleosides Nucleotides 1, 233 (1982);
76. (c) K.K. Ogilvie. G.H. Hakimelahi. Z.A. Proba, and D.P.C. McGee. Tetrahedron Lett. 23, 1997 (1982);
77. 29Si NMR nucleosides and the investigation of 2,4-dinitrobenzenesulfenyl as a protecting group for ribonucleotide synthesis. Ph.D. thesis, McGill University, Montreal, Canada. 1986.
78. (a) M.J. Damha and K.K. Ogilvie. J. Org. Chem. 53. 3710 (1988);
79. (b) M.J. Damha, R.T. Pon, and K.K. Ogilvie. Tetrahedron Lett. 26, 4839 (1985).
80. M.J. Damha. Developments in the chemical synthesis of nucleic acids and their analogues. Ph.D. thesis, McGill University, Montreal, Canada. 1987.
81. The arabino-configured bis-phosphoaramidite does show P-P coupling, but the xylo-configured analogue does not. This data could be compatible with either through-space or through-bond origins of the coupling. See: S. Carriero, M.M. Mangos, K.A. Agha, A.M. Noronha, and M.J. Damha. Nucleosides Nucleotides Nucl. Acids, 22, 1599 (2003).
82. (a) MJ. Damha, N. Usman, and K.K. Ogilvie. Tetrahedron Lett. 28, 1633 (1987);
83. (b) M.J. Damha, N. Usman, and K.K. Ogilvie. Can. J. Chem. 67. 831 (1989).
84. M. Resmini and W. Pfleiderer. Helv. Chim. Acta 76. 158 (1993).
85. (a) T. Mikita and G.P. Beardsley. Biochemistry. 33, 9195 (1994);
86. (b) Y.G. Gao, G.A. Van der Marel, J.H. Van Boom, and A.H.J. Wang. Biochemistry, 30, 9922 (1991);
87. (c) J.M.L. Pieters, E. De Vroom, G.A. Van der Marel, J.H. Van Boom, T.M.G. Koning, R. Kaptein, and C. Altona. Biochemistry, 29, 788 (1990).
88. P.A. Giannaris and MJ. Damha. Can. J. Chem. 72, 909 (1994).
89. A.M. Noronha. C.J. Wilds, C.-N. Lok, K. Viazovkina, D. Arion, M.A. Parniak, and MJ. Damha. Biochemistry, 39, 7050 (2000).
90. MJ. Damha, CJ. Wilds, A. Noronha, I. Brukner, G. Borkow, D. Arion, and M.A. Parniak. J. Am. Chem. Soc. 120, 12976 (1998).
91. J. Minshull and T. Hunt. Nucleic Acids Res. 14, 6433 (1986).
92. J.K. Watts, J. Viladoms, and MJ. Damha. Manuscript in preparation.
93. T. Dowler, D. Bergeron, A.-L. Tedeschi. L. Paquet, N. Ferrari, and M J. Damha. Nucleic Acids Res. 34, 1669 (2006).
94. C.G. Peng and M.J. Damha. Nucleic Acids Res. 35. 4977 (2007).
95. F. Eckstein. Antisense Nucleic Acid Drug Dev. 10, 117 (2000).
96. (a) P.M. Burgers, F. Eckstein, and D.H. Hunneman. J. Biol. Chem. 254. 7476 (1979);
97. (b) P.M J. Burgers and F. Eckstein. Biochemistry, 18, 592 (1979).
98. A. Kalota. L. Karabon. C.R. Swider, E. Viazovkina. M. Elzagheid, M.J. Damha, and A.M. Gewirtz. Nucleic Acids Res. 34, 451 (2006).
99. N. Ferrari, D. Bergeron, A.-L. Tedeschi, M.M. Mangos, L. Paquet. P.M. Renzi, and M.J. Damha. Ann. N.Y. Acad. Sci. 1082, 91 (2006).
100. (a) J.T. Stivers, K.W. Pankiewicz, and K.A. Watanabe. Biochemistry, 38, 952 (1999);
101. (b) A.C. Drohat. G. Xiao, M. Tordova, J. Jagadeesh, K.W. Pankiewicz, K.A. Watanabe, G.L. Gilliland, and J.T. Stivers. Biochemistry. 38, 11876 (1999).
102. On the extra stability provided to RNA by a phosphorothioate backbone, see: M. Ora, M. Oivanen, and H. Lonnberg. J. Org. Chem. 62, 3246 (1997).
103. (a) J.A. Zoltewicz, D.F. Clark, T.W. Sharpless, and G. Grahe. J. Am. Chem. Soc. 92. 1741 (1970);
104. (b) G. Holmquist. Chromosoma. 72, 203 (1979).
105. R.G. Schultz and S.M. Gryaznov. Tetrahedron Lett. 41, 1895 (2000).
106. R. Schultz and S. Gryaznov. Nucleic Acids Res. 24, 2966 (1996).
107. S. Wang and E.T. Kool. Biochemistry, 34, 4125 (1995).
108. K.-L. Min, E. Viazovkina, A. Galarneau, M.A. Parniak, and M.J. Damha. Bioorg. Med. Chem. Lett. 12. 2651 (2002).
109. N. Martin-Pintado, J.K. Watts, C. Gonzalez, and M.J. Damha. Manuscript in preparation.
110. C.J, Wilds. Synthesis, physicochemical and biological properties of oligonucleotides containing 2-fluoro-2-deoxy-β-D-arabinose. Ph.D. thesis, McGill University, Montreal, Canada. 1999.
111. J.K. Watts, N. Choubdar. K. Sadalapure, F. Robert, A.S. Wahba, J. Pelletier, B.M. Pinto, and M.J. Damha. Nucleic Acids Res. 35, 1441 (2007).
112. C.A. Stein, C. Subasinghe, K. Shinozuka, and J.S. Cohen. Nucleic Acids Res. 16, 3209 (1988).
113. C.-N. Lok, E. Viazovkina, K.-L. Min, E. Nagy, C.J. Wilds, M.J. Damha, and M.A. Parniak. Biochemistry, 41, 3457 (2002).
114. J. Lacombe, E. Viazovkina, P.N. Bernatchez, A. Galarneau, M.J. Damha, and M.G. Sirois. Can. J. Physiol. Pharmacol. 80, 951 (2002).
115. A.M. Noronha. Synthesis, physicochemical and biological studies on oligonucleotides containing D-arabinose. Ph.D. thesis, McGill University, Montreal, Canada. 1999.
116. A.M. Sapse and G. Snyder. Cancer Invest. 3, 115 (1985).
117. N. Hicks, O.W. Howarth, and D.W. Hutchinson. Carbohydr. Res. 216, 1 (1991).
118. J. van Wijk, C.A.G. Haasnoot, F.A.A.M. de Leeuw, B.D. Huckriede, A.W. Hoekzema, and C. Altona. PSEUROT. Version 6.3 [computer program]. Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands. 1999.
119. D.B. Davies. Prog. Nucl. Magn. Reson. Spectrosc. 12, 135 (1978).
120. J.K. Watts, K. Sadalapure, N. Choubdar, B.M. Pinto, and M.J. Damha. J. Org. Chem. 71, 921 (2006).
121. J. He, I.A. Mikhailopulo, and F. Seela. J. Org. Chem. 68, 5519 (2003).
122. G.G. Sivets, E.N. Kalinichenko, and I.A. Mikhailopulo. Lett. Org. Chem. 3, 402 (2006).
123. H. Ford, F. Dai, L. Mu, M.A. Siddiqui, M.C. Nicklaus, L. Anderson, V.E. Marquez, and J.J. Barchi. Biochemistry, 39, 2581 (2000).
124. X. Peng and F. Seela. Org. Biomol. Chem. 2, 2838 (2004).
125. A.Y. Denisov, A.M. Noronha, C.J. Wilds, J.-F. Trempe. R.T. Pon, K. Gehring, and M.J. Damha. Nucleic Acids Res. 29, 4284 (2001).
126. F. Seela, P. Chittepu, J. He, and H. Eickmeier. Acta Crystallogr. Sect. C: Cryst. Struct. Commun. 60 o884 (2004).
127. F.H. Martin and I. Tinoco, Jr. Nucleic Acids Res. 8. 2295 (1980).
128. J.-F. Trempe, C.J. Wilds, A.Y. Denisov, R.T. Pon, M.J. Damha, and K. Gehring. J. Am. Chem. Soc. 123, 4896 (2001).
129. D. Venkateswarlu and D.M. Ferguson. J. Am. Chem. Soc. 121, 5609 (1999).
130. G. Minasov, M. Teplova, P. Nielsen, J. Wengel, and M. Egli. Biochemistry, 39, 3525 (2000).
131. N.K. Christensen, M. Petersen, P. Nielsen, J.P. Jacobsen, C.E. Olsen, and J. Wengel. J. Am. Chem. Soc. 120, 5458 (1998).
132. F. Li, S. Sarkhel, C.J. Wilds, Z. Wawrzak, T.P. Prakash, M. Manoharan, and M. Egli. Biochemistry, 45, 4141 (2006).
133. E. Rozners and J. Moulder. Nucleic Acids Res. 32, 248 (2004).
134. The potential of 2′F-ANA as an AON, in the context of other sugar-modified AONs, has been reviewed in: M.M. Mangos and M.J. Damha. Curr Top. Med. Chem. 2, 1147 (2002).
135. M.M. Mangos, K.-L. Min, E. Viazovkina, A. Galarneau, M.I. Elzagheid, M.A. Parniak, and MJ. Damha. J. Am. Chem. Soc. 125, 654 (2003).
136. B.M. Patureau, R.H.E. Hudson, and M.J. Damha. Bioconjugate Chem. 18, 421 (2007).
137. W.F. Lima, J.G. Nichols, H. Wu, T.P. Prakash, M.T. Migawa, T.K. Wyrzykiewicz, B. Bhat, and S.T. Crooke. J. Biol. Chem. 279, 36317 (2004).
138. N. Ferrari. TPI ASM8 and TPI 1100 - Multi-targeted antisense oligonucleotide approaches for the treatment of lung inflammatory diseases. EuroTIDES 2007. Berlin, Germany. 2007.
139. (a) A. Gruenweller, E. Wyszko, B. Bieber, R. Jahnel, V.A. Erdmann, and J. Kurreck. Nucleic Acids Res. 31, 3185 (2003);
140. (b) T.A. Vickers, S. Koo, C.F. Bennett, S.T. Crooke, N.M. Dean, and B.F. Baker. J. Biol. Chem. 278, 7108 (2003).
141. D.R. Corey. J. Clin. Invest. 117, 3615 (2007).
142. M. Manoharan. Curr. Opin. Chem. Biol. 8, 570 (2004).
143. C.J. Wilds and M.J. Damha. Bioconjugate Chem. 10, 299 (1999).
144. C. Escudé, J.-C. Francois, J.-S. Sun, G. Ott, M. Sprinzl, T. Garestier, and C. Hélène. Nucleic Acids Res. 21, 5547 (1993).
145. (a) A.D. Ellington and J.W. Szostak. Nature, 346, 818 (1990);
146. (b) G.F. Joyce. Gene, 82, 83 (1989);
147. (c) C. Tuerk and L. Gold. Science, 249, 505 (1990).
148. E.W.M. Ng, D.T. Shima, P. Calias, E.T. Cunningham, D.R. Guyer. and A.P. Adamis. Nat. Rev. Drug Discov. 5, 123 (2006).
149. K. Gehring, J.-L. Leroy, and M. Gueron. Nature, 363, 561 (1993).
150. S. Robidoux and M.J. Damha. J. Biomol. Struct. Dyn. 15, 529 (1997).
151. C.G. Peng and M.J. Damha. J. Am. Chem. Soc. 129, 5310 (2007).
152. C.G. Peng and M.J. Damha. Can. J. Chem. In press. (2008).
153. E. Viazovkina, K.-L. Min, A. Galarneau, and M.J. Damha. Nucleosides Nucleotides Nucl. Acids 22, 1335 (2003).
154. M.I. Elzagheid. A.L. Tedeschi, and M.J. Damha. Nucleosides Nucleotides Nucl. Acids 22, 1343 (2003).
155. A.-L. Tedeschi. Synthesis and biological evaluation of oligonucleotides containing 3′- and 5′-S-phosphorothiolate internucleotide linkages. M.Sc thesis, McGill University, Montreal, Canada. 2004.
156. B.P. Monia, J.F. Johnston, T. Geiger, M. Mullen and D. Fabbro. Nat. Med. 2, 668 (1996).
157. For reviews, see: A.A. Levin. Biochim. Biophys. Acta, Gene Struct. Expression 1489, 69 (1999);
158. and T.L.H. Jason, J. Koropatnick, and R.W. Berg. Toxicol. Appl. Pharmacol. 201, 66 (2004).